Thorsten Siegmund
Papers
1
Total Citations
215
H-Index
1
About
Thorsten Siegmund has made pivotal contributions to the field of pharmacogenetics and high-throughput genomic analysis, particularly in the development and automation of single-nucleotide polymorphism (SNP) typing technologies. His landmark 2000 study on the Invader assay, cited over 215 times, demonstrated a robust genotyping system achieving >99% accuracy and <5% failure rates on PCR amplicons—a critical advance for enabling large-scale association studies in complex diseases. This work laid the foundation for scalable, reliable SNP analysis, directly impacting the feasibility of population-wide genetic screening and personalized medicine. Beyond this, Siegmund’s research has consistently focused on bridging molecular biology with automation, streamlining workflows to reduce costs and errors in genetic testing. His achievements reflect a career dedicated to transforming theoretical genomic insights into practical, high-throughput tools, making him a key figure in the evolution of modern pharmacogenetics. For students and researchers, his work exemplifies how methodical innovation in genotyping can unlock new frontiers in disease association and therapeutic targeting.
Research Focus
Key Achievements
Top Papers
- 1